Efficacy and safety of first-line combination therapy versus monotherapy for vitreoretinal lymphoma: a systematic review and meta-analysis.

Authors:
Gao J; Peng X; Wang L.

Journal:
BMC Ophthalmol

Publication Year: 2023

DOI:
10.1186/s12886-023-03226-3

PMCID:
PMC10664658

PMID:
37993841

View on PubMed View on PMC View Publisher
Journal Information

Full Title: BMC Ophthalmol

Abbreviation: BMC Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A 12-year follow up survey of childhood blindness at schools for the blind in Cambodia.
Rogerson T; Ath SS; Meng N and 1 more (2024) - Transparency Score: 4/6
Abnormalities of retinal function in type 2 diabetes mellitus patients without clinical diabetic re…
Li RR; Yang Y; Zhang MG and 5 more (2024) - Transparency Score: 3/6
A case of bilateral amyloidosis localized to extraocular muscles mimicking thyroid eye disease.
Yoshida-Hata N; Mimura M; Aikawa M and 1 more (2024) - Transparency Score: 3/6
A case of iridoschisis with partial lens dislocation in both eyes.
Niu TT; Xin WJ. (2024) - Transparency Score: 3/6
A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection …
Shi M; Lu Z; Qin A and 3 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by grants from the National Natural Science Foundation of China (grant No.82170181), Beijing Hospitals Authority Youth Programme (code: QML20200201), and Beijing Natural Science Foundation (No.7222027) to Liang Wang."

Evidence found in paper:

"Trial registration CRD42023400305."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025